A growing body of research showed that elevated cerebrospinal fluid and serum levels of CXCL13 were associated with an increased risk of MS progression.[11, 12] CXCL13 is the most important molecule recruiting B cells to the cerebral spinal fluid for developing lymphoid follicles in the meninges of MS patients. Here, CXCL13 is linked to myeloid sarcoma.